[Dyspnea grade as a prognostic factor in patients with chronic obstructive pulmonary disease].
Associations of body mass index and oxygen saturation with chronic obstructive pulmonary disease grade in patients.
Adherence to Inhaled Medications and its Effect on Healthcare Utilization and Costs Among High-Grade Chronic Obstructive Pulmonary Disease Patients.
Pulmonary rehabilitation for patients with chronic pulmonary disease (COPD): an evidence-based analysis.
COPD Working Group.
Ont Health Technol Assess Ser. 2012;12(6):1-75. Epub 2012 Mar 1.
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.
Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ.
N Engl J Med. 2004 Mar 4;350(10):1005-12. doi: 10.1056/NEJMoa021322.
Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline.
Macrea M, Oczkowski S, Rochwerg B, Branson RD, Celli B, Coleman JM 3rd, Hess DR, Knight SL, Ohar JA, Orr JE, Piper AJ, Punjabi NM, Rahangdale S, Wijkstra PJ, Yim-Yeh S, Drummond MB, Owens RL.
Am J Respir Crit Care Med. 2020 Aug 15;202(4):e74-e87. doi: 10.1164/rccm.202006-2382ST.
Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.
Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Schünemann H, Wedzicha W, MacDonald R, Shekelle P; American College of Physicians; American College of Chest Physicians; American Thoracic Society; European Respiratory Society.
Ann Intern Med. 2011 Aug 2;155(3):179-91. doi: 10.7326/0003-4819-155-3-201108020-00008.
Investigation of the efficacy and potential pharmacological mechanism of Yupingfeng in treating chronic obstructive pulmonary disease: A meta-analysis and in silico study.
Xu Y, Zhang L, Chen C, Zou M, Wang K, Liu X, Kang T, Li M, Wu D, Jiang Z, Liu J.
J Ethnopharmacol. 2025 Mar 13;343:119441. doi: 10.1016/j.jep.2025.119441. Epub 2025 Feb 4.
Breathing Exercises in the Treatment of COPD: An Overview of Systematic Reviews.
Li Y, Ji Z, Wang Y, Li X, Xie Y.
Int J Chron Obstruct Pulmon Dis. 2022 Dec 7;17:3075-3085. doi: 10.2147/COPD.S385855. eCollection 2022.
Risk Factors of Sarcopenia in COPD Patients: A Meta-Analysis.
Zhou J, Liu Y, Yang F, Jing M, Zhong X, Wang Y, Liu Y, Ming W, Li H, Zhao T, He L.
Int J Chron Obstruct Pulmon Dis. 2024 Jul 9;19:1613-1622. doi: 10.2147/COPD.S456451. eCollection 2024.
Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines.
Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, Make B, Rochester CL, Zuwallack R, Herrerias C.
Chest. 2007 May;131(5 Suppl):4S-42S. doi: 10.1378/chest.06-2418.
Assessing Symptom Burden.
Vogelmeier CF, Alter P.
Clin Chest Med. 2020 Sep;41(3):367-373. doi: 10.1016/j.ccm.2020.06.005.
Heart failure and chronic obstructive pulmonary disease: a review.
Horodinschi RN, Bratu OG, Dediu GN, Pantea Stoian A, Motofei I, Diaconu CC.
Acta Cardiol. 2020 Apr;75(2):97-104. doi: 10.1080/00015385.2018.1559485. Epub 2019 Jan 16.
